![Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial](/i/c/1ecdf4b9-ceb1-280f-2b40-f03806a0daa6.webp)
Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
2023-11-27 14:47
![FDA Weighing What to Do About $900,000 Drug That May Not Work](/i/c/89d2e7ea-3b0b-b12f-b46b-3274f6389423.webp)
FDA Weighing What to Do About $900,000 Drug That May Not Work
The cancer drug Folotyn, one of the most expensive in the US, received a short-cut approval from US
2023-11-16 18:52
![An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative](/i/c/49978e69-43ea-f135-61ae-1dc252da1b1c.webp)
An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative
When Krista Marquick discovered kratom, it filled a hole in her life that quitting alcohol had left —
2023-11-10 18:45
![New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper](/i/c/19998c91-0156-05f8-9bef-4b4c8f5d77d5.webp)
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
2023-11-09 07:27
![Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic](/i/c/d8ede3e0-46f5-8734-1145-def85ddcf3f4.webp)
Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic
Eli Lilly & Co. won US approval for its diabetes drug to treat obesity, unlocking blockbuster sales potential
2023-11-09 04:23
![Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled](/i/c/730dc586-f733-a4cc-836c-a3b11fdb4400.webp)
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 05:15
![Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal](/i/c/4d76c9fd-a449-5896-55b1-ee1e46d16fb6.webp)
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:58
![China’s Junshi Nabs FDA Approval in Rare Success for US Foray](/i/c/d8255394-322a-e8e3-425c-bfeb22db98e4.webp)
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
2023-10-28 11:15
![Verve Surges After FDA Lifts Hold on Gene-Editing Therapy](/i/c/f1c464ab-cd04-88d1-9c5e-3174c7cc9fe7.webp)
Verve Surges After FDA Lifts Hold on Gene-Editing Therapy
Verve Therapeutics Inc. surged in premarket trading after US drug regulators lifted their hold on the company’s application
2023-10-23 20:20
![GSK Settles Zantac Lawsuit Set for Trial in California](/i/c/fe9f7904-ad06-81c5-12c9-005a23892a72.webp)
GSK Settles Zantac Lawsuit Set for Trial in California
GSK Plc reached a settlement for another US lawsuit claiming the drugmaker’s blockbuster heartburn medication Zantac causes cancer.
2023-10-11 15:46
![Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion](/i/c/0b294f82-ba78-2a29-1734-1503251679ff.webp)
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:26
![Philips Slumps After Another Blow to Sleep Product Recall](/i/c/2c8e0bce-2f59-1e91-c06b-fe04e425ec9c.webp)
Philips Slumps After Another Blow to Sleep Product Recall
Royal Philips NV suffered another setback as the US drug regulator requested additional tests on its sleep apnea
2023-10-06 16:56